Brief: Alivus Life Sciences Sept-Quarter Standalone Profit 1.3 Billion Rupees
06/11/2025 13:16
Nov 6 (Reuters) - Alivus Life Sciences Ltd ALIV.NS: SEPT-QUARTER STANDALONE PROFIT 1.3 BILLION RUPEES SEPT-QUARTER STANDALONE REVENUE FROM OPERATIONS 5.88 BILLION RUPEES Source text: ID:nBSE4C9dH5 Further company coverage: ALIV.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alivus Life Sciences
See all newsBrief: Alivus Life Sciences Incorporates Subsidiary Alivus Life Sciences Do Brasil Ltda In Brazil
Brief: Alivus Life Sciences To Buy 76% Stake In Iqgen-X Pharma For Approx 91.2 Million Rupees
India's Alivus rises to 15-month high as brokerages optimistic about drugmaker's annual outlook
India's Alivus Life Sciences rises after quarterly profit increase
Brief: Alivus Life Sciences Ltd March-Quarter Profit 1.63 Billion Rupees